High-dose methotrexate with cyclophosphamide and cis-platinum in treatment of advanced ovarian carcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000477:Alkylating Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000009:adverse effects; D001853:Bone Marrow / Q000187:drug effects; D002945:Cisplatin / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects; D002955:Leucovorin / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D012008:Recurrence
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D002945:Cisplatin; D002955:Leucovorin; D008727:Methotrexate